Company / Revenue per Share
Beam Therapeutics Inc. Revenue per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$1.37
FY2025
5-year range
$0.76 / $4.63
FY2021-FY2025
Trend
+80.8%
vs FY2024
Sector context
#100 of 154
Health Care
What the data says
At $1.37, Beam Therapeutics Inc.'s revenue per share ranks #100 of 154 in the Health Care sector. Revenue per Share has fluctuated over the past 7 years, ranging from $0.00 in FY2020 to $4.63 in FY2023.
Based on SEC 10-K filings.
1.37 in FY2025 with a 5-year CAGR of +254.4%.
Declined from $4.63 to $1.37 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +17.1%
- 5-Year CAGR
- +254.4%
- 10-Year CAGR
- -
Sector benchmark
#100 of 154 in Health CareTop 65% of 154This company $1.37 Sector average $15.09
▼
-90.9% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 80.8% year-over-year.
- Ranks #100 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2023.
- Lowest revenue per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.37 | +80.8% |
| FY2024 | $0.76 | -83.6% |
| FY2023 | $4.63 | +441.4% |
| FY2022 | $0.85 | +12.7% |
| FY2021 | $0.76 | +30754.2% |
| FY2020 | $0.00 | -11.6% |
| FY2019 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026